SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Organovo Holdings, Inc. – ‘10-K’ for 3/31/23 – ‘EX-21.1’

On:  Thursday, 7/13/23, at 7:24pm ET   ·   As of:  7/14/23   ·   For:  3/31/23   ·   Accession #:  950170-23-32889   ·   File #:  1-35996

Previous ‘10-K’:  ‘10-K’ on 6/10/22 for 3/31/22   ·   Next & Latest:  ‘10-K/A’ on 7/31/23 for 3/31/23   ·   33 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 7/14/23  Organovo Holdings, Inc.           10-K        3/31/23   75:12M                                    Donnelley … Solutions/FA

Annual Report   —   Form 10-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   2.40M 
 2: EX-3.4      Articles of Incorporation/Organization or Bylaws    HTML    304K 
 3: EX-4.1      Instrument Defining the Rights of Security Holders  HTML     47K 
 4: EX-10.38    Material Contract                                   HTML   3.05M 
 5: EX-21.1     Subsidiaries List                                   HTML     22K 
 6: EX-23.1     Consent of Expert or Counsel                        HTML     22K 
 7: EX-31.1     Certification -- §302 - SOA'02                      HTML     27K 
 8: EX-31.2     Certification -- §302 - SOA'02                      HTML     27K 
 9: EX-32.1     Certification -- §906 - SOA'02                      HTML     26K 
15: R1          Document and Entity Information                     HTML     96K 
16: R2          Consolidated Balance Sheets                         HTML    113K 
17: R3          Consolidated Balance Sheets (Parenthetical)         HTML     32K 
18: R4          Consolidated Statements of Operations and Other     HTML     95K 
                Comprehensive Loss                                               
19: R5          Consolidated Statements of Stockholders' Equity     HTML     63K 
20: R6          Consolidated Statements of Cash Flows               HTML    106K 
21: R7          Description of Business and Summary of Significant  HTML     83K 
                Accounting Policies                                              
22: R8          Investments and Fair Value Measurement              HTML     68K 
23: R9          Fixed Assets                                        HTML     55K 
24: R10         Accrued Expenses                                    HTML     48K 
25: R11         Collaborative Research, Development, and License    HTML     77K 
                Agreements                                                       
26: R12         Stockholders' Equity                                HTML    225K 
27: R13         Leases                                              HTML     93K 
28: R14         Commitments and Contingencies                       HTML     29K 
29: R15         Income Taxes                                        HTML    157K 
30: R16         Concentrations                                      HTML     26K 
31: R17         Related Parties                                     HTML     31K 
32: R18         Defined Contribution Plan                           HTML     27K 
33: R19         Recent Accounting Pronouncements                    HTML     35K 
34: R20         Description of Business and Summary of Significant  HTML    123K 
                Accounting Policies (Policies)                                   
35: R21         Recent Accounting Pronouncements (Policies)         HTML     24K 
36: R22         Investments and Fair Value Measurement (Tables)     HTML     61K 
37: R23         Fixed Assets (Tables)                               HTML     52K 
38: R24         Accrued Expenses (Tables)                           HTML     47K 
39: R25         Collaborative Research, Development, and License    HTML     40K 
                Agreements (Tables)                                              
40: R26         Stockholders' Equity (Tables)                       HTML    185K 
41: R27         Leases (Tables)                                     HTML     77K 
42: R28         Income Taxes (Tables)                               HTML    141K 
43: R29         Description of Business and Summary of Significant  HTML     74K 
                Accounting Policies - Additional Information                     
                (Detail)                                                         
44: R30         Investments and Fair Value Measurement -            HTML     42K 
                Additional Information (Detail)                                  
45: R31         Investments and Fair Value Measurement - Summary    HTML     32K 
                of Investments in Debt Securities that are                       
                Measured at Fair Value (Detail)                                  
46: R32         Investments and Fair Value Measurement - Schedule   HTML     34K 
                of Activity for Investments in Equity Securities                 
                Measured at Fair Value (Detail)                                  
47: R33         Fixed Assets - Schedule of Fixed Assets (Detail)    HTML     36K 
48: R34         Fixed Assets - Additional Information (Detail)      HTML     24K 
49: R35         Accrued Expenses - Summary of Accrued Expenses      HTML     33K 
                (Detail)                                                         
50: R36         Collaborative Research, Development, and License    HTML    103K 
                Agreements - Additional Information (Detail)                     
51: R37         Collaborative Research, Development, and License    HTML     30K 
                Agreements - Schedule of Capitalized License Fees                
                (Detail)                                                         
52: R38         Stockholders' Equity - Preferred Stock -            HTML     26K 
                Additional Information (Detail)                                  
53: R39         Stockholders' Equity - Common Stock - Additional    HTML     90K 
                Information (Detail)                                             
54: R40         Stockholders' Equity - Summary of Company's RSUs    HTML     44K 
                Activity (Detail)                                                
55: R41         Stockholders' Equity - Stock Options and Employee   HTML     86K 
                Stock Purchase Plan - Additional Information                     
                (Detail)                                                         
56: R42         Stockholders' Equity - Summary of Stock Option      HTML     55K 
                Activity (Detail)                                                
57: R43         Stockholders' Equity - Common Stock Reserved for    HTML     42K 
                Future Issuance (Detail)                                         
58: R44         Stockholders' Equity - Schedule of Stock-based      HTML     29K 
                Compensation Expense (Detail)                                    
59: R45         Stockholders' Equity - Stock-based Compensation     HTML     35K 
                Expense and Valuation Information - Additional                   
                Information (Detail)                                             
60: R46         Stockholders' Equity - Fair Value of Employee       HTML     34K 
                Stock Options (Detail)                                           
61: R47         Stockholders' Equity - Fair Value of ESPP Shares    HTML     38K 
                (Detail)                                                         
62: R48         Stockholders' Equity - Fair Value of Employee       HTML     26K 
                Stock Purchase Plan (Parenthetical) (Detail)                     
63: R49         Leases - Additional Information (Details)           HTML     55K 
64: R50         Leases - Schedule of Lease Liabilities and          HTML     40K 
                Corresponding Right-of-use Assets (Details)                      
65: R51         Leases - Schedule of Future Lease Payments          HTML     44K 
                (Details)                                                        
66: R52         Income Taxes - Summary of Reconciliation of         HTML     66K 
                Statutory Federal Rate and Effective Rate for                    
                Operations (Detail)                                              
67: R53         Income Taxes - Summary of Net Deferred Tax Assets   HTML     55K 
                (Detail)                                                         
68: R54         Income Taxes - Additional Information (Detail)      HTML     53K 
69: R55         Related Parties - Additional Information (Detail)   HTML     27K 
70: R56         Defined Contribution Plan - Additional Information  HTML     26K 
                (Details)                                                        
73: XML         IDEA XML File -- Filing Summary                      XML    132K 
71: XML         XBRL Instance -- onvo-20230331_htm                   XML   1.72M 
72: EXCEL       IDEA Workbook of Financial Report Info              XLSX    126K 
11: EX-101.CAL  XBRL Calculations -- onvo-20230331_cal               XML    181K 
14: EX-101.DEF  XBRL Definitions -- onvo-20230331_def                XML    516K 
10: EX-101.LAB  XBRL Labels -- onvo-20230331_lab                     XML   1.31M 
13: EX-101.PRE  XBRL Presentations -- onvo-20230331_pre              XML    941K 
12: EX-101.SCH  XBRL Schema -- onvo-20230331                         XSD    184K 
74: JSON        XBRL Instance as JSON Data -- MetaLinks              403±   672K 
75: ZIP         XBRL Zipped Folder -- 0000950170-23-032889-xbrl      Zip    635K 


‘EX-21.1’   —   Subsidiaries List


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  EX-21.1  

Exhibit 21.1

Subsidiaries of Organovo Holdings, Inc.

 

I.
Organovo, Inc., a Delaware corporation
II.
Opal Merger Sub, Inc., a Delaware corporation

 



7 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/30/24  Organovo Holdings, Inc.           S-1/A                 81:12M                                    Donnelley … Solutions/FA
 4/12/24  Organovo Holdings, Inc.           S-1                   76:11M                                    Donnelley … Solutions/FA
 2/08/24  Organovo Holdings, Inc.           424B5                  1:315K                                   Donnelley … Solutions/FA
 2/08/24  Organovo Holdings, Inc.           10-Q       12/31/23   61:6.2M                                   Donnelley … Solutions/FA
 1/26/24  Organovo Holdings, Inc.           S-3                    5:1M                                     Donnelley … Solutions/FA
12/01/23  Organovo Holdings, Inc.           S-8        12/01/23    4:98K                                    Donnelley … Solutions/FA
 7/31/23  Organovo Holdings, Inc.           10-K/A      3/31/23   12:1.4M                                   Donnelley … Solutions/FA


26 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

10/25/22  Organovo Holdings, Inc.           S-8        10/25/22    6:283K                                   Donnelley … Solutions/FA
10/14/22  Organovo Holdings, Inc.           8-K:5,9    10/12/22   11:546K                                   ActiveDisclosure/FA
 6/10/22  Organovo Holdings, Inc.           10-K        3/31/22   76:8.3M                                   ActiveDisclosure/FA
11/19/21  Organovo Holdings, Inc.           8-K:1,9    11/17/21   11:2M                                     ActiveDisclosure/FA
10/06/21  Organovo Holdings, Inc.           8-K:5,9    10/05/21   12:553K                                   ActiveDisclosure/FA
 3/25/21  Organovo Holdings, Inc.           S-8         3/25/21    5:169K                                   Donnelley … Solutions/FA
 3/10/21  Organovo Holdings, Inc.           8-K:5,9     3/05/21    3:193K                                   Donnelley … Solutions/FA
 2/08/21  Organovo Holdings, Inc.           10-Q       12/31/20   54:5.4M                                   ActiveDisclosure/FA
12/31/20  Organovo Holdings, Inc.           8-K:1,9    12/28/20    2:182K                                   ActiveDisclosure/FA
11/25/20  Organovo Holdings, Inc.           8-K:1,9    11/23/20    3:3.2M                                   ActiveDisclosure/FA
11/05/20  Organovo Holdings, Inc.           10-Q        9/30/20   56:5.5M                                   ActiveDisclosure/FA
 8/17/20  Organovo Holdings, Inc.           8-K:3,5,8,9 8/17/20    3:67K                                    ActiveDisclosure/FA
 5/20/20  Organovo Holdings, Inc.           8-K:5,9     5/19/20    2:56K                                    ActiveDisclosure/FA
 1/29/20  Organovo Holdings, Inc.           8-K:1,9     1/26/20    2:43K                                    Donnelley … Solutions/FA
12/16/19  Organovo Holdings, Inc.           8-K:1,5,8,912/13/19    7:797K                                   Donnelley … Solutions/FA
 8/14/18  Organovo Holdings, Inc.           S-8         8/14/18    5:145K                                   Donnelley … Solutions/FA
 7/27/18  Organovo Holdings, Inc.           8-K:5,9     7/26/18    3:185K                                   ActiveDisclosure/FA
 3/16/18  Organovo Holdings, Inc.           8-K:1,9     3/16/18    3:211K                                   Donnelley … Solutions/FA
 4/24/17  Organovo Holdings, Inc.           S-8         4/24/17    5:156K                                   Donnelley … Solutions/FA
 8/18/16  Organovo Holdings, Inc.           8-K:5,7,9   8/17/16    3:104K                                   Donnelley … Solutions/FA
 8/04/16  Organovo Holdings, Inc.           10-Q        6/30/16   51:4.1M                                   ActiveDisclosure/FA
11/09/15  Organovo Holdings, Inc.           10-Q        9/30/15   48:4.4M                                   ActiveDisclosure/FA
 6/09/15  Organovo Holdings, Inc.           10-K        3/31/15   72:11M                                    ActiveDisclosure/FA
 5/11/12  Organovo Holdings, Inc.           8-K/A:1,2,3 2/08/12    4:1.5M                                   Donnelley … Solutions/FA
 2/13/12  Organovo Holdings, Inc.           8-K:1,2,3,4 2/08/12   30:6M                                     EdgarAgents LLC/FA
 2/03/12  Organovo Holdings, Inc.           8-K:3,5,8,9 1/30/12    7:686K                                   EdgarAgents LLC/FA
Top
Filing Submission 0000950170-23-032889   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 16, 9:38:55.3pm ET